The FDA approved Lipfendra, the first oral PCSK9 inhibitor by Merck, marking a new way to treat hypercholesterolemia with a daily pill.
This article was originally published by 9News Colorado (RSS) on Thursday, July 16, 2026. TownPost surfaces local news from over 40 outlets and uses AI to score each story for relevance to Longmont and the surrounding area.
Relevance score: 20/100. This story has regional context that may affect Longmont.
TownPost does not modify or rewrite source content. Read the full article at its original publication for complete coverage.
